Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Kyoto University Innovation Capital Co., Ltd. (Kyoto iCAP) is a venture capital firm founded in December 2014, fully funded by Kyoto University. The firm is headquartered at the International Science Innovation Building in Kyoto, Japan. Kyoto iCAP's mission is to commercialize the research outcomes of Kyoto University and other national universities, thereby fostering innovation and entrepreneurship. The firm plays a vital role in connecting academic research with market applications, ensuring that groundbreaking discoveries translate into viable business opportunities.
Kyoto iCAP manages a total of approximately ¥54 billion (around $360 million) across three funds, including the Innovation Kyoto 2016 Fund and the Innovation Kyoto 2021 Fund. The firm focuses on seed to early-stage investments, emphasizing milestone-based funding to support startups in their growth journey. Kyoto iCAP has established itself as a key player in the venture capital landscape, particularly in the biotech and healthcare sectors, leveraging the extensive research capabilities of Kyoto University.
Kyoto iCAP specializes in investing in seed and early-stage companies that aim to commercialize research outcomes from national universities, particularly Kyoto University. The firm primarily targets sectors such as biotechnology, healthcare, IoT, and deep tech. Investments typically range from pre-seed to growth equity stages, with a strong emphasis on milestone-based funding. This approach allows the firm to support startups through various phases of development, ensuring they have the necessary resources to succeed.
Geographically, Kyoto iCAP focuses on Japan, specifically targeting national university spinouts. The firm collaborates with private venture capitalists and financial institutions for follow-on funding, enhancing the growth potential of its portfolio companies. Kyoto iCAP's unique investment strategy includes a long fund duration of up to 20 years, which is particularly suited for the commercialization timelines of basic research.
Kyoto iCAP has built a diverse portfolio of companies across various sectors, showcasing its commitment to supporting innovative startups. Notable investments include:
Ko Kusumi: President and CEO of Kyoto iCAP, Ko Kusumi has extensive experience in venture capital and entrepreneurship, focusing on bridging the gap between academia and industry.
Nobuhiro Yagi: Executive Officer and Senior Officer in Investment Department 1, Nobuhiro Yagi specializes in business development and has a strong background in managing investments in early-stage companies.
Hiroyuki Ueno: Executive Officer and Senior Officer in Investment Department 2, Hiroyuki Ueno brings expertise in business development and investment management, focusing on supporting startups in their growth phases.
Osami Kono: Executive Officer and Senior Officer in the Business Development Department, Osami Kono has a wealth of experience in investment strategies and startup support.
Masayoshi Ohbayashi: A key member of the Investment Department, Masayoshi Ohbayashi contributes to the firm's investment strategies and portfolio management.
Masahiro Shinohara: Manager in the Investment Department, Masahiro Shinohara focuses on identifying promising startups and supporting their development.
Satoru Morita: Manager in the Investment Department, Satoru Morita plays a crucial role in evaluating investment opportunities and supporting portfolio companies.
Startups interested in pitching to Kyoto iCAP should use the contact form available on their website. It is essential to include a comprehensive business plan, details about the research outcomes being commercialized, and information on the founding team. The firm appreciates pitches that clearly outline the market potential and the innovative aspects of the technology.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are beneficial, particularly from individuals within the academic or venture capital community, as they can enhance the credibility of the pitch.
Kyoto University Innovation Capital operates several programs designed to support entrepreneurship and innovation. The Entrepreneur-in-Residence (EIR-iCAP) program provides aspiring entrepreneurs with the resources and mentorship needed to develop their business ideas. Participants receive guidance on business planning, market analysis, and commercialization strategies.
The Entrepreneurial Collaboration Program (ECC-iCAP) is aimed at business professionals looking to start their ventures. This program facilitates collaboration between researchers and entrepreneurs, fostering the development of new business ideas based on academic research.
Kyoto University Innovation Capital has recently been active in the startup ecosystem, with notable investments including Lattera Corporation. The firm continues to expand its portfolio, focusing on companies that commercialize research outcomes from national universities.
In addition to its investment activities, Kyoto iCAP has been enhancing its support programs for entrepreneurs, including the Entrepreneur-in-Residence (EIR-iCAP) and the Entrepreneurial Collaboration Program (ECC-iCAP). These initiatives aim to foster innovation and collaboration between researchers and startups.
What are Kyoto iCAP's investment criteria?
Kyoto iCAP invests in seed to early-stage companies that aim to commercialize research outcomes from national universities, particularly Kyoto University. The firm focuses on sectors such as biotechnology, healthcare, IoT, and deep tech.
How can startups apply or pitch to Kyoto iCAP?
Startups can pitch to Kyoto iCAP through their contact form available on their website. It is recommended to include a detailed business plan and information about the research outcomes being commercialized.
What makes Kyoto iCAP different from other venture capital firms?
Kyoto iCAP is unique due to its strong ties with Kyoto University, allowing it to leverage cutting-edge research and technologies. The firm also offers milestone-based investments and has a long fund duration of up to 20 years, which is particularly beneficial for deep science commercialization.
What is the geographic scope of Kyoto iCAP's investments?
Kyoto iCAP primarily focuses on investments within Japan, specifically targeting national university spinouts. This geographic focus allows the firm to tap into the rich research environment of Japanese universities.
What kind of post-investment involvement does Kyoto iCAP have?
Kyoto iCAP provides extensive support for commercialization, including consultations on company establishment, management personnel searches, and introductions to private venture capital and financial institutions for follow-on funding.
What is the size of Kyoto iCAP's funds?
Kyoto iCAP manages approximately ¥54 billion (around $360 million) across its three funds, which allows for significant investment in early-stage companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.